Home > Healthcare > Medical Devices > Diagnostic Devices > Immunoassay Interference Blocker Market

Immunoassay Interference Blocker Market Share

Report ID: GMI4427
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Immunoassay Interference Blocker Market Share

The competitive landscape of the immunoassay interference blocker industry is characterized by the presence of established biopharmaceutical companies that involved in the manufacturing of technologically advanced immunoassay interference blocker vying for market share. Key players are engaging in strategic initiatives such as product launch, collaboration, investment, and partnerships to strengthen their product portfolio. The companies are actively adopting a multi-pronged approaches to address the rising demand for immunoassay interference blocker.

Immunoassay Interference Blocker Market Companies

Prominent players operating in the immunoassay interference blocker industry are as mentioned below:

Meridian Bioscience
F. Hoffmann La Roche Ltd.
Candor Bioscience GmbH
Nordic Biosite
Bio-Rad Laboratories Inc.
Aviva Biosystem Biology Corporation
Scantibodies Laboratory Inc.
Rockland Immunochemicals Inc.
Abcam PLC
Thermo Fisher Scientific Inc.
Surmodic IVD Inc.
Electron Microscopy Science
Merck KGaA
Jackson ImmunoResearch Inc.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global immunoassay interference blocker market was valued at USD 289.2 million in 2023 and will grow at 6.3% CAGR during 2024-2032, driven by the growing prevalence of chronic diseases.

The antibody interference blocker product segment in the immunoassay interference blocker industry held a revenue of USD 155.6 million in 2023 and will expand rapidly till 2032, as it provides better accuracy of the assay.

North America immunoassay interference blocker market held 43.2% revenue share in 2023 and will grow rapidly till 2032, owing to a well-established healthcare infrastructure.

Meridian Bioscience, F. Hoffmann La Roche Ltd., Candor Bioscience GmbH, Nordic Biosite, Bio-Rad Laboratories Inc., Aviva Biosystem Biology Corporation, Scantibodies Laboratory Inc., and Rockland Immunochemicals Inc. among others.